Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. Learn more about REPL stock here.
Liverpool reporter David Lynch has named Paris Saint-Germain defender Illya Zabarnyi as a prospective transfer target worth ...
The Amex Platinum earns very little on everyday spending. But carrying the right second card can close that gap on groceries, ...
Crypto news today is shifting toward Ethereum as bullish Ethereum price prediction models examine whether ETH could eventually reach $8,500. The target sits well above current market levels, but ...
Researchers at the University of Illinois Chicago have identified a molecular switch that helps determine whether cancer ...
The Cubs are possibly looking to shake things up by trading Seiya Suzuki and utilizing their depth while trying to enhance ...
Magnitude of EO2463-induced CD8 T-cell expansion during monotherapy statistically significantly associated with longer progression-free survival (PFS) in patients w ...
Jersey Mike’s set the expected price range for its IPO at $21 to $25 per share, putting the sandwich chain’s implied valuation between $6.67 billion and $7.94 billion. At the proposed price range, the ...
Discover how the Atlanta Braves might target offense as they navigate the MLB trade deadline with trade possibilities.
Warm and muggy temperatures are once again plaguing portions of the East Coast, but thick Canadian wildfire smoke could throw ...
Effective Anti-Drone Warfare demands a complete kill chain - detection, identification, tracking, and hard-kill engagement - ...
The World Health Organization ( WHO ) has labelled tuberculosis as the world's leading infectious disease killer. With more than 10 million cases of active tub ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results